The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale
Launched by UNIVERSITY OF UTAH · Mar 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The MyLungHealth Study is designed to help improve lung cancer screening for patients who may be at risk. The trial focuses on using a patient-friendly approach through an online health portal to identify eligible patients and support them in making informed decisions about lung cancer screening. By addressing common barriers, such as missing information about patients' smoking history, the study aims to increase the number of people screened for lung cancer using low-dose computed tomography (LDCT), a special type of X-ray that helps find lung cancer early.
To participate in this study, individuals should be between 50 and 79 years old with a history of smoking, either current or former. Specifically, those with a history of smoking at least 10 pack-years (which means smoking about one pack a day for 10 years) may be eligible. Participants will be recruited from primary care clinics and can expect to engage with the online portal to help guide their screening decisions. This study is currently looking for volunteers, and it’s a great opportunity for those who want to take an active role in their lung health.
Gender
ALL
Eligibility criteria
- Inclusion criteria for both study 1 and study 2:
- • aged 50-79
- • a history of smoking (e.g., current or former tobacco use)
- • seen in a study primary care clinic in the 12 months preceding the start of the trial
- Exclusion criteria for both study 1 and study 2:
- • \>0 but \< 10 pack-year smoking history or quit more than 15 years ago
- • No use of the patient portal at least once in the year preceding the start of the study
- • A lung cancer diagnosis at the start of the study
- • LDCT completed in the past 3 years
- • Another chest CT completed in the past year
- • Structured EHR data indicating LCS SDM was provided in the past 3 years
- • Exposed to the intervention during the pilot phase
- Inclusion criteria for study 1:
- • a 10-19 pack-year smoking history, an unknown pack-year history, unknown quit date for patients who quit smoking, or a 0 pack-year smoking history
- Inclusion criteria for study 2:
- • at least a 20 pack-year smoking history and are a current smoker or have quit within the last 15 years
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Kensaku Kawamoto, MD, PhD, MHS
Principal Investigator
University of Utah
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported